Searched for
NESHER PHARMA
- Cadila Healthcare Q3 net dips by 4.4%, sales rise 20%Cadila Healthcare, the flagship company of Zydus group, has suffered a 4.4% drop in its third quarter net profit on account of forex losses.08 Feb, 2012, 12.07 PM IST
- Zydus Cadila buys out Biochem PharmaceuticalsZydus Cadila has acquired 100% stake in Mumbai-based Biochem Pharmaceuticals for an undisclosed amount.22 Dec, 2011, 03.53 AM IST
- Zydus Cadila in talks to acquire brands and manufacturing facility of Biochem PharmaceuticalsThe deal is expected to be valued at Rs 300-450 cr and will boost Biochem's revenue growth. In fiscal 2009-10, Biochem reported revenues of...25 Jul, 2011, 01.10 AM IST
- Zydus Cadila Q1 net up 15.38% at Rs 229.82 croreAhmedabad-based Zydus Cadila today said its consolidated net profit rose by 15.38 per cent to Rs 229.82 crore in the first quarter ended Ju...19 Jul, 2011, 04.30 PM IST
- Zydus plans to buy US drug cos for $60 mnZydus Cadila plans to acquire US-based generic pharma company. The Ahmedabad-based firm signed an asset purchase agreement with a US-based ...17 Jun, 2011, 10.54 PM IST
Load More- Cadila Healthcare Q3 net dips by 4.4%, sales rise 20%
